News

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, ...
The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...